 |
|
| Blog results | Results 1 - 10 of about 23,492 for drug generic maker. (0.23 seconds) |
| Sorted by relevance Sort by date |
| 2 hours ago by pharmafeed Ratiopharm, the family-owned generic drug maker is collecting bids right now — and as we noted recently, there have been reports that several private equity shops are interested, including KKR, TPG, Permira and Goldman Sachs's ... PharmaFeed - http://www.pharmafeed.com/ |
| 14 hours ago King Climbs as Drug Companies Lure Private Equity Bloomberg A week later, German generic-drug maker Ratiopharm GmbH drew bids of about $3 billion from TPG, KKR & Co., Advent International Corp. and the private-equity . ... Pharmainfo.net - http://www.pharmainfo.net/ |
| 10 Nov 2009 by Phil Here's another terrific post by Pharmboy, this time discussing Generic Drug Makers. - Ilene Generic Drug Makers Courtesy of Pharmboy Coming to the end of. Phil's Stock World - http://www.philstockworld.com/ - References |
| 22 Nov 2009 by Andrew Welsh-huggins Wyeth had filed a suit in the District Court of Columbia against the US Food and Drug Administration's (FDA) decision to grant Orchid permission to sell generic Zosyn, chemically Piperacillin-Tazobactam, claiming the drug could harm ... Health News - http://blog.taragana.com/health/ [ More results from Health News ] |
| 18 Nov 2009 mlive.com -- West Michigan generic drug maker Perrigo Co. is hiring to fill 60 positions at its headquarters and production sites in Allegan. Openings include field professionals, scientists and production supervisors, Kim Shriver, ... BioSpace.com Featured News and Stories - http://www.biospace.com/ [ More results from BioSpace.com Featured News and Stories ] |
| 6 Nov 2009 Makers of generic drugs produce copycat versions of popular drugs whose patents have expired. Under the Hatch-Waxman Act, the first to successfully challenge a drug's patent gets exclusive rights to sell the drug for about six months. ... Investors.com - http://www.investors.com/NewsAndAnalysis/ - References [ More results from Investors.com ] |
| 8 hours ago by admin All deceptive errors year with the militant large drugs, but each general makes and does its political policies in generic times, mircette prescription assistance program. Lives this using have a transparency? There is often a important practice of an unwanted ... Cigarettes, never social bugs or population humans killed in prescriptions of consensus, for act of disease, and for the maker of many communities, receive to help marketers and freebies over opponent. ... Dr Zord's Blog - http://jochenmoser.com/ |
| 20 Nov 2009 Record profits. Job openings. Shareholders making money. It's not what you might think in Michigan, home to the country's highest unemployment rate, but a century-old company is in robust health thanks to achy, thifty Americans. Economy/AP - http://www.washingtonexaminer.com/economy/ap/ |
| 11 Nov 2009 by pillscribe Swedish drug maker AstraZeneca has filed a lawsuit against India's generic firm Lupin for allegedly violating its valid patents on its gastric reflux disease drug Nexium (esomeprazole magnesium delayed release capsules) though seeking ... DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/ [ More results from DWS Pill Scribe ] |
| 18 hours ago Valeant's share price has doubled since March, and last week the stock traded at a 50% premium to other specialty drug makers on a valuation basis thanks to excitement over the experimental-seizure drug retigabine, which Valeant and ... The market also has many generic seizure medications or drugs that require fewer daily doses than retigabine. If retigabine can't sustain Valeant's premium stock multiple, the shares could loose one third of their value, Alpert says. ... Barron's Markets - http://online.barrons.com/home-page [ More results from Barron's Markets ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
